Posted on 2/25/21
Medisafe Secures $30M in Series C
Medisafe, a leading digital therapeutics company creating digital drug companions, today announced that it has raised $30 million in Series C funding with investments led by . . .
Posted on 2/25/21
Cellarity Raises $123M in Series B
Cellarity, a life sciences company founded by Flagship Pioneering to develop a new method of drug discovery targeting the cell, announced today that it raised $123 . . .
Posted on 2/25/21
Great Hill Partners Joins $90M Series C for Terminus
Terminus, the leading account-based marketing platform, announced today it raised a $90 million Series C from Boston-based Great Hill Partners with participation from existing
Posted on 2/24/21
Malta Raises $50M
Malta Inc., a pioneer in long-duration energy storage, today announced it has raised $50M in a Series B round of funding.
Posted on 2/24/21
Xilio Therapeutics Raises $95 Million in Series C
Xilio Therapeutics, a biotechnology company developing potent, tumor-selective immunotherapies for patients with cancer, today announced the successful closing of a $95 million Series C financing.
Posted on 2/24/21
Orna Therapeutics Raises $100M
Orna Therapeutics, a Cambridge, Mass.-based biotechnology company dedicated to designing and delivering a new class of fully engineered circular RNA therapeutics (oRNAs), completed an $80m Series . . .
Posted on 2/23/21
Capstone Headwaters Advises Seraxis on $40M Series C Financing Round
Capstone Headwaters, a leading middle market investment banking firm, advised Seraxis, Inc., a biotech company developing a cell replacement therapy for insulin-dependent diabetes, on its recently . . .
Posted on 2/22/21
ABclonal Biotechnology Raises $93 Million Series C
ABclonal Biotechnology, a global life science tools and services provider, recently completed its $92.9 million Series C financing led by Sequoia Capital China and healthcare-focused
Posted on 2/22/21
Creatio Raises $68M
Creatio, a Boston, MA-based global software company that provides a low-code platform for process management and CRM, raised $68M in funding.
Posted on 2/22/21
ABclonal Biotechnology Closes $93M Series C
ABclonal Biotechnology, a Woburn, Mass.-based global life science tools and services provider, completed its $92.9m Series C financing.
Posted on 2/18/21
Locus Robotics Raises $150 Million In Series E
Locus Robotics, the leader in autonomous mobile robots (AMR) for fulfillment warehouses, today announces $150 million in Series E funding, led by Tiger Global Management and . . .
Posted on 2/17/21
OutSystems Raises $150M at $9.5 Billion Valuation
OutSystems, a Lisbon, Portugal and Boston, MA-based provider of a modern application platform, raised $150m in funding
Posted on 2/17/21
Battery Ventures Closes $400 Million Select Fund I
Battery Ventures, a global, technology-focused investment firm, has closed Battery Ventures Select Fund I, a new, $400 million vehicle designed to deliver additional capital to a . . .
Posted on 2/17/21
Elicio Therapeutics Secures $73 Million in Series B
Elicio Therapeutics, a private biotechnology company developing a pipeline of potent immunotherapies based on its proprietary lymph node targeting technology, announced the successful completion
Posted on 2/17/21
ImmuneID Launches with $17M Financing
ImmuneID, Inc., a precision immunology company employing a proprietary platform to identify and therapeutically target antibody interactions that drive immune diseases, announced a $17M financing led
Posted on 2/16/21
Ampion PBC Closes $10M Series A
Ampion PBC, the revenue-management software platform solution for Community Solar and other Distributed Generation Assets, today announced it has completed a $10M Series A
Posted on 2/16/21
Highland Electric Transportation Raises $253 Million
Highland Electric Transportation, a provider of turnkey fleet solutions delivering the latest in zero-emission technologies to school districts and fleet managers, has raised $253M
Posted on 2/16/21
Centessa Pharmaceuticals Launches with $250 Million Series A Financing
Centessa Pharmaceuticals launched today as a novel asset-centric pharmaceutical company designed and built to advance a portfolio of highly validated programs. Centessa’s asset-centric
Posted on 2/11/21
Baring Private Equity Asia Completes Acquisition of Virtusa
Baring Private Equity Asia and its affiliated funds today announced that BPEA has successfully completed the acquisition
Posted on 2/11/21
Cyteir Therapeutics Secures $80 Million in Series C
Cyteir Therapeutics, a leader in the discovery and development of next-generation synthetic lethal therapies for cancer, today announced the close of an oversubscribed $80 million Series . . .
Posted on 2/11/21
Nobl9 Raises $21M in Series B
Nobl9, a Boston, MA-based software reliability platform company, secured $21m in Series B funding.
Posted on 2/10/21
Hyperfine Raises $90 Million in Series D
Hyperfine Research has closed an oversubscribed $90 Million Series D financing round, with support from investors including GV (formerly Google Ventures), Nextrans (KClavis-Nextrans), Axiom Associates, Huami, . . .
Posted on 2/10/21
Labster Secures $60M in Series C Funding Led by Andreessen Horowitz
Labster, a Boston, MA-based producer of virtual laboratory simulations, raised $60m in Series C funding.
Posted on 2/9/21
Thrasio Raises $750M
Thrasio announced today that it has completed another round of financing, adding $750,000,000 to its balance sheet
Posted on 2/9/21
beam Closes $5 Million Series A
beam, the direct-to-consumer wellness brand most notably known for its innovative, THC-free CBD product offerings, announced today the completion of a $5 million Series A financing . . .
Boston
